Are you Dr. Wong?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2946 E Banner Gateway Dr
Gilbert, AZ 85234Phone+1 480-256-6444Fax+1 480-256-4607
Summary
- Dr. Bryan Wong, MD is an oncologist in Gilbert, Arizona. He is currently licensed to practice medicine in Arizona, Nevada, and New York. He is affiliated with Banner Gateway Medical Center.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2005
Tufts Medical CenterResidency, Internal Medicine, 1998 - 2001
Lewis Katz School of Medicine at Temple UniversityClass of 1998
Certifications & Licensure
AZ State Medical License 2009 - 2026
NY State Medical License Active through 2012
NV State Medical License 2005 - 2011
Clinical Trials
- Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma Start of enrollment: 2011 Feb 01
- An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 9 citationsA Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate CancerThai H. Ho, Rafael Nunez-Nateras, Yue Xian Hou, Alan H. Bryce, Donald W. Northfelt
Clinical Genitourinary Cancer. 2017-04-01 - 5 citationsPhase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma.Matthew D. Galsky, Noah M. Hahn, Bryan Wong, Karen M. Lee, Pamela Argiriadi
Cancer Chemotherapy and Pharmacology. 2015-10-13 - 25 citationsPhase I Studies of CBP501, a G2 Checkpoint Abrogator, as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid TumorsGeoffrey I. Shapiro, Raoul Tibes, Michael S. Gordon, Bryan Y. Wong, Joseph Paul Eder
Clinical Cancer Research. 2011-05-15
Professional Memberships
- Member
